Regulatory Affairs
Drug-approval processes; regulatory bodies (CDSCO, US FDA, ICH); dossier preparation and regulatory compliance for global markets.
Shree Sai Prakashan is writing a full set of B.Pharm titles to this new NEP 2020 syllabus. Get notified the moment the book for this subject is released, or pre-book sets for your college.
Course contents — unit by unit · PCI NEP 2020 BP707T
Unit 1 · Fundamentals of Regulatory Affairs 6 hrs
An introduction to drug regulatory affairs; an overview of the principal regulatory agencies including the CDSCO, US FDA, EMA and PMDA; the organizational structure of regulatory bodies; and the role and responsibilities of the regulatory-affairs professional.
Unit 2 · Regulations, Laws and Acts 6 hrs
The regulations, laws and acts governing pharmaceuticals; and the principal regulatory references including the Orange Book, the Purple Book, the Federal Register and the Code of Federal Regulations.
Unit 3 · Regulatory Requirements in Drug Development 6 hrs
The regulatory requirements at each stage of drug development — preclinical studies, the Investigational New Drug application, the phases of clinical trials, and Good Clinical Practice; together with the ICH guidelines that apply.
Unit 4 · Dossier Preparation and the Common Technical Document 6 hrs
The structure and modules of the Common Technical Document (CTD) and electronic CTD; the preparation and compilation of a registration dossier; and the New Drug Application and Abbreviated New Drug Application routes.
Unit 5 · Global Registration and Post-Approval Activities 6 hrs
Registration requirements in the major and emerging markets; post-approval changes, variations and supplements; labelling and packaging requirements; and regulatory inspections and compliance.
← Full B.Pharm Fourth Year syllabus All 8 semesters — B.Pharm NEP 2020 syllabus →
Adopting the new NEP 2020 B.Pharm syllabus?
Pre-book new-syllabus B.Pharm sets at institutional pricing.